PPT-An Introduction to HSCT

Dr Mustafa CETIN 2 5 th November 201 6 After the atomic bomb explosion in Japan ending WW2 many scientists began to explore ways of protecting humans from irradiation How haematopoietic stem cell transplant was born. Patient with MF has Increasing . B. lasts, but Not . Y. et AML -- What to . D. o? . John Mascarenhas, MD. Myeloproliferative Disorders . Program. Tisch. . Cancer Institute, Division of Hematology/Oncology . LTFU Under 12 yrs clinic (GOSH) Paediatric Oncology Shared Care Unit (POSCU) (Shared Care) LTFU Over 12 yrs clinic (GOSH) Continuing LTFU GOSH clinics Up to 16 – 18 years Transition Clinics Can you confidently abandon CMV seronegative products in the modern era of pre-storage leukoreduction?. Jeannie Callum, BA, MD, FRCPC. Really?. Are we still talking. about this in 2017?. Disclosure. MSc. University of Tennessee College of . Health Sciences. Memphis, TN. . . Learning Objectives. Upon completion, participants should be able to:. Review treatment regimens for patients with relapsed ALL. Learning objectives. To understand the difference between allogeneic and autologous HSCT. To understand the types of and reasons for the different HSCT conditioning regimens. To recognise potential complications associated with HSCT. Collection of Survival and Clinical Data for Multicenter Clinical Trials Using the Qlikview App Provided By CIBMTR 02/20/2019 1:55 PM Presentation Anderson João Simione Data Analyst Hospital Amaral Carvalho Guenther Koehne, MD, PhD. Adult . Bone Marrow Transplant Service. Division of Hematologic Oncology. Department of Medicine. Memorial Sloan-Kettering Cancer Center. New York, New York. Autologous SCT. Presented by:. Dr.Naser. . Shagerdi. . Esmaeli. Assistant Professor of Azad Medical University. Tabriz Branch. Peripheral T Cell Lymphomas (PTCLs). Incidence rate of peripheral T‑cell lymphomas (PTCLs. adolescents: recommendations from an international expert panel –BFM . blood- 2012 ,120: 3187-3205. . Absence . of published . recommendations specific . for pediatric . AML . motivated an international . Clinical Advances in Hematology Oncology Volume 15 Issue 2 February 2017Classic PresentationClassic signs and symptoms of VOD/SOS include ascites and painful hepatomegaly Severe disease can lead to Razazian. Associate Professor of Neurology. 1397. International . Journal of Hematology Oncology and Stem Cell Research . . Feasibility of cell therapy in Multiple Sclerosis: A systematic review of 83 studies . + . + . -. T1 T2 . . T1 T3. Chemotherapy Protocol AAML1031. ARAC (IT + IV)/DAUN /ETOP. ARAC (IT+IV)/DAUN/MITOX. HD ARAC. KMT2A-BTK. : A NEW . clinical. . symptoms. Allo. -HSCT. Fever. Erythroderma. Hypoxemia. Hypotension. Other cardiac dysfunctions. Capillary-leak. Renal impairment. GI symptoms. CNS dysfunctions. COVID-19 sCRS. 13/17 (76%). A Pediatric Transplant Infectious Diseases Learning Module. Using the Modules. The modules are case-based, with decision points (branches) containing questions. Many questions don’t have right or wrong answers.